Rabid Growth at Crucell
498150
Crucell signs a marketing agreement with Sanofi, but who benefits more?
269730
Things could be better for the Goth retailer.
543833
There&#39;s plenty of vroom vroom these days at Vivendi Universal as the disparate parts of the restructured conglomerate are increasingly firing in synch.
209415
The insurance-focused software firm struggles for growth.
69736
The storage company keeps growing like a weed.
678517
This week has demonstrated that the builders are still hurting.
348955
The stock looks reasonably valued but some core businesses are struggling to grow.
617748
PHILADELPHIA -- Money's a little tight right now for Fred Cratil as he and some relatives put the finishing touches on their new Italian restaurant.
551900
After big layoffs and management turmoil, the developer of the metaverse There looked near death. But $14 million in new funding has pumped some life into the company. By Daniel Terdiman.
81746
The retailer wallows in penny-stock pain.
474975
Cash'n'Carrion Lots of torch for not much cash
720865
A look at this West Coast retailer reveals a market-crushing year-to-date run.
567102
NORTON - Faced with a few more miles to go and traffic like he hadn't expected, Steve Stricker had a bit of a sinking feeling in his stomach yesterday.
419865
CBRL sheds the beef but profit watchers still have some beefs.
679788
Pioneer struggles with turnover at its highest levels.
618671
Since the K5 Emperor of Icecream, eavier, foisted the augean task of ghetto-reviewing onto my skinny shoulders this year, here goes. First, we begin with the grimy w/hole itself, and then move to the individual rotting parts thereof. The obvious changes to the ghetto landscape were: trhurler didn't come back from his hike, MichaelCrawford started giving it away, my kuron brethren were badly trolled by a xanax-popping dysfunctional alcoholic), both Egil and insomnyuk decided to suicidomize themselfs, NIWS/Spellcheckbot attacked (again), and rusty took apart his bathroom and added walls to K5.   Rotting parts inside:
470074
Omnicare's expansion of its CRO unit seems unwise given its effort to acquire a major rival.